Constipation can look simple from the outside. The biology behind it can be very different from one person to another — and for some people, inherited gut-motility susceptibility may be part of the picture.
Constipation can look simple from the outside.
You are not having bowel movements often enough.
But the biology behind constipation can be very different from one person to another.
One person may have:
Another may have:
Another may have:
And some people seem to have had unusually slow digestion or bowel function for most of their lives.
That raises a reasonable question:
Can constipation or slow gut motility be partly genetic?
Yes.
Research increasingly supports a genetic contribution to traits such as:
But there is no single:
“constipation gene.”
And common genetic variants cannot diagnose:
A more useful genetic question is:
Does my DNA suggest lower inherited reserve in biological systems that help move material through the gastrointestinal tract?
Mutant Genomics evaluates that question within the Gut Motility, Digestion & Bile hub and ranks gut-related findings alongside thyroid, autonomic, metabolic, nutrient, histamine, and other biological hypotheses.
Relevant genetic markers
↓
Genetic module patterns
↓
Converging patterns
↓
Ranked health hypotheses
↓
Supporting evidence + DNA coverage
↓
Health Context
The goal is not to diagnose constipation from DNA.
It is to determine whether inherited gut-motility susceptibility is worth considering—and whether your actual health history supports it.
Your top 3 ranked health hypotheses are included in full with Mutant Free. No credit card required.
Your complete raw DNA stays in your browser. Mutant retains only the genetic markers needed for your analysis.
Partly.
Bowel habits are influenced by combinations of:
Genetics may influence baseline susceptibility.
It does not determine your bowel pattern by itself.
No.
DNA can provide susceptibility context.
Actual motility depends on current physiology and may require:
when clinically appropriate.
No single common gene explains most cases.
Multiple biological systems contribute to intestinal movement.
The more useful model is:
several genetic influences on motility reserve
rather than:
one defective constipation gene.
Compatible 23andMe raw DNA may contain some markers relevant to Mutant’s gut-motility models.
Coverage varies by testing version.
Missing markers remain:
missing
rather than being interpreted as normal.
Gut motility describes the coordinated movement of material through the gastrointestinal tract.
That includes movement through:
Different regions use different:
Motility is therefore not a single process.
You can digest food reasonably well and still have slow transit.
Likewise, someone can have:
while experiencing:
Mutant therefore separates several biological mechanisms inside the broader:
Gut Motility, Digestion & Bile
hub.
The gastrointestinal tract contains its own extensive nervous system:
the enteric nervous system
It coordinates:
Gut movement also depends on interactions with:
This is one reason constipation can have many different causes.
The word constipation can describe several different patterns.
Here, material moves unusually slowly through the colon.
Possible symptoms can include:
Actual slow transit requires appropriate clinical evaluation.
Genetics cannot establish it.
In another pattern, stool reaches the rectum but evacuation is difficult.
Symptoms may include:
The primary problem may involve coordination of:
rather than slow transit through the entire colon.
IBS-C may involve:
IBS is not diagnosed from genetic variants.
Many medications can reduce gastrointestinal movement or stool passage.
Examples may include some:
Medication context can sometimes explain the bowel pattern better than the genetics.
Constipation can also occur with conditions involving:
A gut-motility genetic hypothesis should therefore be compared with broader Health Context.
Large genetic studies suggest that bowel frequency and related gastrointestinal traits are influenced by many genetic loci.
These findings point toward biology involving:
This supports an important idea:
Normal variation in gut movement is partly heritable.
But these common variants generally have modest effects.
They do not let us look at one SNP and conclude:
“You have slow-transit constipation.”
Instead of imagining:
good motility genes
versus:
bad motility genes
it can be more useful to think about:
motility reserve
A person may inherit slightly less reserve across several biological mechanisms.
For example:
less favorable enteric neural signaling
+
less secretory support
+
greater autonomic susceptibility
may create a system that works normally under favorable circumstances but becomes more vulnerable under:
The genetics represent the baseline.
The environment determines how much pressure is placed on that baseline.
Your DNA may remain essentially the same while your bowel function changes substantially.
Possible reasons include:
A previously adequate motility system may eventually have:
less remaining reserve.
That can make inherited susceptibility more noticeable.
Family members can share:
So a family history of constipation may suggest a genetic contribution.
It does not prove one.
The family pattern may reflect:
genes + shared environment
rather than genetics alone.
The gut contains neurons that regulate:
Genetic variation affecting:
may contribute to differences in gastrointestinal motility.
Mutant can evaluate selected inherited patterns related to this biology.
That does not measure current enteric nerve function.
Acetylcholine is an important neurotransmitter involved in gastrointestinal motor activity.
Cholinergic signaling contributes to:
Genetic differences affecting cholinergic biology may contribute to motility susceptibility.
But:
cholinergic gene variant ≠ diagnosed motility disorder.
Medication effects may also strongly influence this system.
Serotonin plays important roles in gastrointestinal physiology.
Much of the body’s serotonin is associated with the gastrointestinal system.
Gut serotonin signaling can influence:
But this does not mean:
constipation = low serotonin
or:
serotonin gene = constipation diagnosis.
Serotonin biology is complex and tissue-specific.
A person may have serotonin-related genetic findings affecting several tissues.
Those findings cannot directly tell you:
Mutant treats gastrointestinal and neurochemical patterns as related but distinct biological contexts.
Movement through the intestine requires coordinated contraction of smooth muscle.
This depends on:
Rare genetic disorders can profoundly disrupt intestinal smooth-muscle or enteric-neural function.
Common variants may have much smaller effects.
Mutant is primarily using common and selected inherited evidence to generate hypotheses—not diagnosing rare gastrointestinal motility diseases from one SNP.
Bile acids are best known for helping digest and absorb fats.
But they also participate in gastrointestinal signaling.
Bile-acid physiology can influence:
This creates an important bridge between:
Digestion
and:
Motility
inside Mutant’s Gut Motility, Digestion & Bile hub.
Different bile-acid patterns can contribute to different bowel phenotypes.
For example, excessive bile acids reaching the colon can contribute to:
while other disruptions in bile-acid physiology may affect:
The biology is not simply:
more bile = faster
or:
less bile = constipation.
Mutant therefore treats bile-related genetics as one part of a broader digestive model.
Stool movement depends partly on:
A colon containing very dry stool may behave differently from one containing well-hydrated stool.
Genetics related to epithelial and secretory biology may therefore influence bowel patterns.
Current hydration and diet still matter greatly.
Sometimes the problem described as:
slow digestion
is partly a fermentation problem.
Poorly absorbed carbohydrates can increase:
That may interact with motility.
A possible pattern is:
slower movement
+
greater fermentation
↓
more distension and discomfort
This can make many foods appear intolerable.
Bloating and constipation do not establish:
These are separate clinical questions.
Genetics can identify susceptibility around:
but cannot diagnose SIBO.
The gut is influenced by the autonomic nervous system.
Stress can affect:
Some people experience:
faster bowel activity during stress
while others experience:
slower digestion or constipation.
This is one reason Mutant evaluates:
Stress & Autonomic Regulation
separately from gut genetics.
Thyroid hormones contribute to gastrointestinal motility.
Reduced thyroid function can be associated with:
This creates an important cross-system hypothesis:
thyroid-related slowing
↓
reduced gastrointestinal motility
↓
greater digestive pressure
But thyroid genetics cannot establish current hypothyroidism.
The relevant Health Context includes actual thyroid testing.
Peristalsis requires:
Normal cellular function also depends on adequate:
Genetic susceptibility involving energy or nutrient handling may therefore modify motility reserve indirectly.
This does not mean constipation can be diagnosed as:
mitochondrial dysfunction
from common SNPs.
A person may not have one dramatic cause.
Instead:
moderately slower inherited motility reserve
+
constipating medication
+
low food volume
+
poor sleep
=
significant constipation
Another person may have:
normal transit genetics
+
pelvic-floor dysfunction
and experience equally severe symptoms.
Those are completely different mechanisms.
Suppose Mutant identifies strong gut-motility susceptibility.
But Health Context shows:
The correct conclusion may be:
The genetic motility susceptibility exists, but it may not be particularly relevant to the current constipation problem.
That is not a failed analysis.
That is appropriate hypothesis testing.
These categories are not mutually exclusive.
A person can have:
and:
at the same time.
This is another reason symptom description matters.
Symptoms that may increase interest in a transit-related hypothesis include:
These symptoms do not diagnose slow transit.
They simply provide relevant Health Context.
Examples include:
These may suggest that pelvic-floor or outlet function deserves attention.
Genetics cannot distinguish these patterns without Health Context.
Someone can have a bowel movement every day and still experience:
Another person may have bowel movements every other day and feel completely well.
The important variables include:
not frequency alone.
Stool form can help describe bowel patterns.
Harder stool forms may occur with:
Looser stool may reflect:
Stool form is useful context.
It is not a genetic test.
When gastrointestinal transit slows, material remains in the gut longer.
That may increase:
A possible pattern is:
slower transit
↓
greater fermentation and retention
↓
more bloating and food sensitivity
The last meal may then appear to be the problem.
But the overall intestinal load may be more important.
Suppose bowel contents are already accumulating.
Another meal introduces:
Symptoms appear.
It may feel like:
“I suddenly cannot tolerate this food.”
But the actual issue may involve:
how the entire gastrointestinal system is processing cumulative meals.
Slow transit may also interact indirectly with histamine-related symptoms.
Longer retention can potentially increase:
For someone with lower histamine-handling reserve, a possible pattern is:
lower histamine-clearance susceptibility
+
slow intestinal movement
↓
narrower food tolerance
This remains a hypothesis.
Constipation does not diagnose histamine intolerance.
Reduced thyroid function can contribute to:
A possible cross-system pattern is:
thyroid-related susceptibility
+
enteric-motility susceptibility
producing less reserve than either one alone.
Actual thyroid function requires laboratory context.
When people develop:
they may progressively reduce food intake.
This can reduce:
That may itself reduce bowel movement.
A possible cycle is:
Food reactions
↓
greater restriction
↓
lower food volume and energy intake
↓
slower bowel function
↓
more digestive symptoms
↓
more restriction
The genetics did not change.
The physiological environment did.
Significant under-eating can also influence:
Those changes may further alter bowel function.
This is why a shrinking diet can sometimes become part of the constipation problem.
Medication history is essential Health Context.
Different drugs can influence bowel movement through mechanisms involving:
If constipation begins shortly after a medication change, that chronology may provide stronger evidence than a common genetic susceptibility.
Supplements can also change stool patterns.
For example, depending on formulation and dose:
may contribute to:
may contribute to:
may loosen stool in some formulations or doses.
may improve stool patterns for some people but increase:
in others.
Genetics cannot determine the ideal supplement strategy.
Fiber can help many forms of constipation.
But responses vary.
Someone with:
may not experience the same benefit as someone with mild low-fiber constipation.
The response to fiber can provide Health Context.
It does not identify the genetic mechanism.
If magnesium improves bowel movements, that tells you something about:
It does not prove:
magnesium deficiency caused the constipation.
Likewise, poor response does not prove:
a genetic magnesium problem.
Different constipation treatments work through different mechanisms.
A response may provide useful clinical information.
But improvement does not automatically tell you:
why the constipation developed.
For example, increasing stool water can help even when the original cause involves:
Treatment response and cause are related but different questions.
Genetics becomes most useful when the question is:
Why might this person’s system have less motility reserve than another person’s?
Mutant may evaluate selected evidence involving:
One common SNP should not determine the conclusion.
There is no single Mutant number that claims:
Your constipation is 82% genetic.
That would imply precision the available evidence does not support.
Instead, Mutant evaluates distinct genetic mechanisms and asks whether they converge on a broader health hypothesis.
Mutant groups related genetic evidence into genetic modules representing more specific biological functions.
Within gut biology, relevant modules may contribute context involving:
Other systems may contribute supporting context.
Several independent modules can support the same broader hypothesis.
For example:
enteric-motility susceptibility
+
autonomic regulation susceptibility
+
thyroid-related motility context
may provide stronger support for a slow-motility hypothesis than any one genetic result.
Another pattern might be:
enteric-motility susceptibility
+
carbohydrate-digestion / fermentation pressure
which could make:
more biologically coherent.
Convergence does not prove current dysfunction.
It increases the amount of genetic evidence supporting the hypothesis.
Suppose one module suggests somewhat lower motility reserve.
Other evidence may be reassuring.
The final hypothesis may therefore remain weak.
This is important because:
More genetic data should not automatically produce a worse interpretation.
Additional evidence may:
the hypothesis.
Mutant does not automatically make:
Gut Motility
the answer because you searched for constipation.
Gut findings are ranked alongside hypotheses involving:
A non-gut hypothesis may rank higher.
That is intentional.
Symptoms:
Mutant:
Health Context:
A motility-centered hypothesis may become more interesting.
Symptoms:
Mutant:
Health Context:
The genetic motility finding may become secondary.
Symptoms:
Mutant:
Health Context:
The medication timeline may be more important than the genetics.
Symptoms:
Mutant:
Health Context:
The thyroid hypothesis may become the more direct explanation for the current constipation.
Symptoms:
Mutant:
Health Context:
A cross-system gut-centered hypothesis may gain support.
Genetics gives the inherited layer.
Health Context helps determine whether it fits the current bowel pattern.
Useful information may include:
Useful information includes:
Chronology can dramatically change the interpretation.
Useful information may include:
Useful information may include:
Useful information may include:
When available, useful information may include:
Useful information may include:
A motility-related genetic hypothesis may become more relevant when there is:
The same genetic hypothesis may become less relevant if:
A good Mutant hypothesis should be able to lose.
The genetic susceptibility exists, but it may not be particularly relevant to the current constipation pattern.
That is not a contradiction.
It means genetics and current physiology are being kept separate.
Not with one routine blood test.
There is no single laboratory marker for:
genetic slow transit.
But labs can help identify competing or contributing causes.
Depending on the clinical situation, relevant testing might include:
Testing should be driven by the clinical question—not by every genetic variant.
For selected people, gastrointestinal testing may provide more direct evidence about:
This is more directly related to current motility than common genetic variants are.
Genetics and motility testing answer different questions.
Did I inherit susceptibility that may reduce motility reserve?
How is the gastrointestinal system functioning now?
These data can complement one another.
They should not be confused.
Suppose genetics strongly support an enteric-motility susceptibility.
But appropriate current testing is reassuring.
The correct interpretation may be:
Inherited susceptibility exists, but there is little evidence of current slow transit.
The genetics do not override the functional evidence.
The reverse is equally important.
A person can have objectively abnormal motility because of:
without Mutant finding a strong genetic pattern.
Current disease does not require a genetic explanation.
Constipation usually does not follow a simple:
one parent → one gene → one bowel pattern
inheritance model.
Common constipation susceptibility is likely influenced by many variants.
Rare inherited motility disorders follow different genetic rules.
Mutant’s common-variant gut analysis should not be confused with clinical testing for rare gastrointestinal genetic disease.
Rare pathogenic variants can cause significant disorders affecting:
Examples of severe inherited gastrointestinal disease may require specialized clinical genetics.
Mutant is not a comprehensive rare motility-disorder diagnostic service.
A lifelong history can increase interest in inherited biology.
But severe constipation beginning:
especially when associated with:
may require clinical evaluation beyond common SNP analysis.
A new bowel pattern should not automatically be attributed to genetics.
Relevant factors may include:
Genetic susceptibility does not explain sudden change by itself.
Seek medical evaluation for constipation associated with symptoms such as:
Emergency symptoms require prompt care.
Genetics alone does not determine the treatment.
Appropriate management depends on the actual mechanism.
For example:
slow transit
and:
pelvic-floor dysfunction
may require very different approaches.
Likewise:
medication-induced constipation
may require a different strategy from:
thyroid-related slowing.
Mutant therefore does not generate a universal constipation protocol from SNPs.
Mutant is not a treatment-selection engine.
Genetics cannot reliably determine whether you should use:
Those decisions depend on:
A common genetics workflow is:
variant found
↓
supplement recommended
Mutant avoids that model.
A gut-motility hypothesis may identify:
less inherited reserve
without establishing:
Once Mutant structures the genetic hypothesis, AI can help compare it with:
The distinction matters:
Mutant interprets the genetics.
AI helps connect it to the rest of the health story.
Instead of asking:
“Do my genes cause constipation?”
try questions such as:
Does my bowel history support the Mutant motility hypothesis?
Do my symptoms look more like slow transit or evacuation difficulty?
Could medication explain the pattern better than genetics?
Do my thyroid results strengthen or weaken a thyroid-related motility explanation?
Does constipation appear to precede my food reactions?
What evidence in my medical records argues against slow transit?
Which competing explanation fits better?
These are more useful because the genetics are treated as a hypothesis.
Suppose Mutant identifies:
AI can compare that with:
It might conclude:
The gut-motility hypothesis appears central, while histamine-related symptoms may become worse when intestinal transit slows.
Or:
Current thyroid dysfunction provides stronger evidence for the bowel slowing than the inherited gut pattern does.
Or:
Pelvic-floor dysfunction better explains the constipation, making the genetic motility hypothesis less relevant.
That is what Health Context is designed to do.
AI should not simply receive:
Mutant found gut motility susceptibility. Find evidence confirming it.
A better instruction is:
Evaluate this gut-motility hypothesis against bowel history, medical records, medications, thyroid testing, diet, and gastrointestinal testing. Identify evidence that strengthens it, evidence that weakens it, and alternative explanations. Do not assume the genetics explain the constipation.
That reduces confirmation bias.
Medical records can add information such as:
A long record may reveal that what appears genetically plausible has already been evaluated.
Do not provide AI only abnormal results.
Reassuring findings can weaken a hypothesis.
For example:
Gut-motility susceptibility
+
normal transit testing
is different from:
Gut-motility susceptibility
+
documented delayed transit.
That difference matters.
Mutant supports compatible data from:
The same underlying Gut Motility, Digestion & Bile analysis framework applies.
What changes is:
which relevant markers are available.
Compatible 23andMe data may contain useful markers related to Mutant’s gut models.
Coverage varies by testing generation.
Some relevant markers may be absent.
A missing variant is treated as:
Missing data
not:
Normal
and not:
No genetic susceptibility.
Compatible AncestryDNA may also provide useful coverage.
The available markers differ from 23andMe.
That means one person’s gut module may have:
while another may have:
because the DNA source differs.
WGS generally provides broader coverage of Mutant’s modeled markers.
That may result in:
But WGS does not diagnose constipation.
It provides more complete genetic evidence.
This is important.
Suppose consumer DNA provides:
several susceptibility variants
but several compensating markers are missing.
WGS may reveal those missing markers.
The final hypothesis might:
The goal is not:
find more constipation genes.
It is:
improve evidence completeness.
Mutant separates gut biology into two hubs.
This hub focuses on biological patterns involving areas such as:
This separate hub focuses more on:
These systems interact.
But they are not the same biological question.
Slow transit can change:
That may alter intestinal pressure.
But constipation does not automatically mean:
“leaky gut.”
Likewise, gut-barrier genetics do not diagnose current intestinal permeability.
Mutant ranks hypotheses across the whole analysis.
For someone with constipation, a gut-motility hypothesis may rank highly.
But another person may have stronger genetic evidence for:
The symptom does not determine the rank.
The evidence does.
Mutant evaluates Gut Motility, Digestion & Bile as part of your overall biological-systems analysis.
Mutant Free includes:
Your top 3 hypotheses may come from any system or hub.
A gut-motility hypothesis is included in full if it ranks among your top 3 overall findings.
No credit card required.
Mutant Full unlocks all remaining findings available from your analysis.
Included:
You can start free and upgrade later.
Mutant Free does not run a smaller gut analysis.
The same underlying Mutant framework generates the findings.
Your top 3 ranked health hypotheses are fully unlocked.
All remaining hypotheses are also unlocked.
There is no separate:
free constipation hub.
Mutant does not upload or store your complete raw DNA file.
When you add compatible DNA data:
You do not need to complete a questionnaire to generate your Mutant genetic analysis.
Health Context is optional.
It can come from:
Mutant does not diagnose:
Mutant provides:
educational genetic context and ranked health hypotheses.
Mutant cannot directly measure:
Those require other forms of Health Context.
Arrange appropriate medical evaluation for constipation associated with:
Seek urgent care for severe symptoms such as:
Constipation is easy to describe.
Its causes can be difficult to separate.
The bowel depends on interactions among:
Genetics may influence several of those systems.
But genetics does not determine the current bowel state.
A better framework is:
Inherited motility reserve
+
current diet and food intake
+
medications
+
thyroid and metabolic context
+
autonomic context
+
pelvic-floor function
+
other gastrointestinal conditions
=
current bowel pattern
Mutant evaluates the inherited layer through:
Relevant genetic markers
↓
Genetic module patterns
↓
Converging patterns
↓
Ranked health hypotheses
↓
Supporting evidence + DNA coverage
↓
Health Context
The most useful questions are not:
“Which constipation gene do I have?”
They are:
Does my DNA suggest less inherited gut-motility reserve?
Do several independent genetic mechanisms converge on that hypothesis?
Does my actual bowel history support it?
Could medication, thyroid dysfunction, diet, or pelvic-floor function explain the pattern better?
What evidence would weaken the genetic hypothesis?
A good gut-motility hypothesis should be able to become stronger.
It should also be able to lose.
Mutant interprets the genetics.
AI helps connect it to the rest of your health story.
Your top 3 ranked health hypotheses are included in full with Mutant Free.
No new DNA test required. No credit card required.
Your complete raw DNA stays in your browser.
There appears to be a heritable component to bowel frequency and gastrointestinal motility.
But constipation is influenced by many genetic and non-genetic factors.
No single common gene explains most constipation.
Multiple biological systems influence motility.
Genetic variation may influence inherited susceptibility involving:
But actual slow digestion requires broader evaluation.
Genetics may contribute to susceptibility.
They cannot diagnose slow-transit constipation.
Inherited biology may contribute to a lifelong pattern.
But other causes, including pelvic-floor dysfunction, diet, medications, and medical conditions, should also be considered.
Research suggests stool frequency has a genetic component.
It is still strongly influenced by:
No.
There is normal individual variation.
A healthy bowel pattern is not defined by genotype.
No.
Current transit requires clinical and physiological context.
Enteric nervous-system dysfunction can influence gastrointestinal movement.
Common genetics may provide susceptibility context.
They cannot diagnose current enteric nerve dysfunction.
Serotonin participates in gastrointestinal signaling.
Common serotonin-related variants do not diagnose constipation or establish low gut serotonin.
There is no reliable rule that a common COMT genotype causes constipation.
COMT is not a constipation gene.
Thyroid-related susceptibility may contribute context because thyroid dysfunction can slow gastrointestinal movement.
Actual thyroid function requires laboratory evaluation.
No.
Thyroid testing and gut-motility genetics answer different questions.
A reassuring thyroid evaluation may reduce the relevance of a thyroid-centered constipation hypothesis while leaving other gut mechanisms possible.
Reduced thyroid signaling can contribute to slower gastrointestinal movement.
A low T3 result can also occur for several reasons and should not automatically be interpreted as a conversion disorder.
Slow transit may increase:
and may narrow tolerance in susceptible people.
This does not prove histamine intolerance.
Constipation can contribute to:
which may make food reactions appear more pronounced.
It does not establish a specific food intolerance.
One possible explanation is that reduced intestinal load lowers:
This observation can provide useful Health Context.
Some people with altered small-intestinal microbial patterns experience constipation.
But constipation alone does not diagnose SIBO.
No.
Mutant does not diagnose SIBO from common SNPs.
No.
Host genetics may influence the intestinal environment.
It cannot determine the current microbial composition of your gut.
FUT2 and secretor biology may influence host–microbe and mucosal context.
A FUT2 variant alone does not diagnose constipation.
Bile-acid biology can influence intestinal secretion and motility.
But constipation is not automatically a bile-acid problem.
Gallbladder and bile disorders can affect digestion.
Constipation has many other potential mechanisms.
A genetic bile-related finding does not diagnose gallbladder disease.
Yes.
Diet can substantially influence bowel function regardless of genetics.
Yes.
Very low food intake can reduce:
and may also affect broader metabolic physiology.
Potentially.
Severe restriction may reduce:
and can contribute to slower bowel function.
Medication can be a major contributor to constipation regardless of genetic susceptibility.
Some antihistamines can contribute to constipation, depending on the medication.
Medication effects should be considered in the full context.
Iron supplements can contribute to constipation and gastrointestinal discomfort.
A reaction does not establish a genetic iron problem.
Calcium supplements may contribute to constipation in some people.
Not necessarily.
Some magnesium preparations can increase stool water through direct gastrointestinal effects.
A response does not prove magnesium deficiency.
Genetics cannot reliably determine whether a probiotic will improve constipation.
Responses depend on:
Not reliably.
Mutant does not generate probiotic prescriptions from common SNPs.
No.
Treatment response depends on the actual constipation mechanism and medical context.
No.
Pelvic-floor dysfunction requires appropriate clinical evaluation.
Yes.
The two patterns can coexist.
Slow motility susceptibility may contribute to a pattern involving:
but bloating has many possible causes.
Not directly.
Upper and lower gastrointestinal motility may interact, but reflux has several distinct mechanisms.
No.
Gastroparesis requires evidence of delayed gastric emptying in the appropriate clinical context and absence of mechanical obstruction.
Compatible 23andMe data may provide some of the markers used by Mutant’s gut models.
Coverage varies.
Compatible AncestryDNA can also provide some relevant markers.
Coverage differs from 23andMe.
WGS generally provides broader coverage of Mutant’s modeled markers.
It does not diagnose constipation.
No.
Additional DNA may:
The purpose is evidence completeness.
Yes.
This can be useful for comparing a Mutant motility hypothesis against:
No.
AI can discuss genetic susceptibility.
Actual slow transit requires current physiological and clinical evidence.
No.
Mutant generates educational genetic health hypotheses.
No.
Mutant does not generate a universal constipation-risk score.
It evaluates biological patterns that may contribute to motility-related hypotheses.
Free access is not assigned by hub.
Mutant Free includes your top 3 ranked health hypotheses across your entire analysis in full.
If a gut-motility hypothesis ranks among your top 3, you can explore it completely with Mutant Free.
Mutant Full is $49/year and unlocks:
No.
The same underlying Mutant framework generates your findings.
Free and Full determine how many of those findings you can open.
No.
Your complete raw DNA is read locally in your browser.
Only the genetic markers required for your analysis are sent and retained.
No.
The questionnaire is optional.
Health Context can also come from:
Mutant provides educational and informational genetic analysis. Mutant findings are health hypotheses, not diagnoses, and are not a substitute for medical evaluation, gastrointestinal testing, motility testing, pelvic-floor evaluation, laboratory testing, clinical genetic testing, medication management, or treatment.